.

Don Drakeman - Advisor

Don is an advisor to Akriveia Therapeutics.

During his 25 years in the industry, Don has overseen the progress of over 30 innovative new medical products for cancer, infectious disease and inflammation from research concept into clinical trials. Several of them have now become FDA-approved therapeutic products for cancer and other diseases. Don is also a venture partner at Advent Life Sciences, a role he took on in 2007.

In that time, he co-founded two multi-billion dollar biotech companies: Medarex Inc and Genmab A/S. Under his leadership as CEO, Medarex raised over a billion dollars, formed alliances with many pharmaceutical companies, developed numerous therapeutic products and spun-off Genmab, which completed Europe’s largest biotech IPO to date.

Don received an AB from Dartmouth College, a JD from Columbia University and a PhD in the Humanities from Princeton University, where he has served as a member of the faculty. He is currently a Fellow in Health Management at the University of Cambridge.